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Few data are available regarding the recirculation of natural killer (NK) cells among human
organs. Earlier studies have been often impaired by the use of markers then proved to be
either not sufﬁciently speciﬁc for NK cells (e.g., CD57, CD56) or expressed only by subsets
of NK cells (e.g., CD16). At the present, available data conﬁrmed that human NK cells popu-
late blood, lymphoid organs, lung, liver, uterus (during pregnancy), and gut. Several studies
showed that NK cell homing appears to be subset-speciﬁc, as secondary lymphoid organs
and probably several solid tissues are preferentially inhabited by CD56brightCD16neg/dull
non-cytotoxic NK cells. Similar studies performed in the mouse model showed that lymph
node and bone marrow are preferentially populated by CD11bdull NK cells while blood,
spleen, and lung by CD27dull NK cells. Therefore, an important topic to be addressed in
the human system is the contribution of factors that regulate NK cell tissue homing and
egress, such as chemotactic receptors or homeostatic mechanisms. Here, we review
the current knowledge on NK cell distribution in peripheral tissues and, based on recent
acquisitions, we propose our view regarding the recirculation of NK cells in the human
body.
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INTRODUCTION
Natural killer (NK) cells are a class of lymphocytes characterized
by a wide spectrum of effector functions spanning from killing of
target cells, mainly tumor and virally-infected cells, to the ability
to inﬂuence various steps of the immune response, such as editing
dendritic cells (DCs) and inﬂuencing emerging T helper response
(Moretta et al., 2003; Ferlazzo, 2005; Fink et al., 2007; Vivier et al.,
2011; Morandi et al., 2012). It is now clear that NK cells are not
exclusively found in peripheral blood (PB) but populate different
tissues and organs. Nonetheless, the true distribution of NK cells
across the human body is less than clear. The task of depicting a
detailed analysis of NK cell distribution is also complicated by the
recent discovery of other innate populations of lymphocytes that
share some characteristics (i.e., NKp46, CD56) with conventional
NK cells and can populate the same compartments (Spits and Di
Santo, 2011).
Contrarily to B and T cells, recirculation and trafﬁcking of NK
cells are almost unknown. Although NK cells express an ample
array of chemotactic receptors, the role of the different chemokine
in guiding in vivo trafﬁcking of NK cells through the tissues
remains poorly dissected. The distribution of NK cells seems to
be subset-speciﬁc in mouse, as different NK cell subsets showed
organ-speciﬁc localizations. Conversely, this issue has been poorly
investigated in the human system. Here, we provide our viewpoint
about distribution and trafﬁcking of NK cells across tissues in the
human system.At the same time,wewill comment previous results
in the light of new discoveries on NK cell speciﬁc features and on
new NK-like cell populations.
DISTRIBUTION OF NK CELLS IN HUMAN NON-LYMPHOID
ORGANS
Information on NK cell distribution across human tissues was
limited by methodological shortcomings, as earlier analyses often
relied on the use of erroneous markers for the detection of NK
cells [i.e., the use of markers then proved to be either not suf-
ﬁciently speciﬁc for NK cells (e.g., CD57, CD56) or expressed
only by subsets of NK cells (e.g., CD16)]. Furthermore, inter-
pretation of studies performed with NK cells in the tissues is
complicated by the fact that most studies have not been able
to distinguish bona ﬁde NK cells from the growing population
of innate lymphoid cells (ILCs). In fact, as cited before, one of
the challenge in identifying tissue NK cells lies in the difﬁculty
in discriminating these cells from other NKp46+ ILC, such as
NKp46+ RORγt+ cells. These latter ILCs, both in human and
mouse, are functionally distinct from conventional NK cells and
have been referred to as NK-22 cells or ILC22 cells. They share
with NK cells the expression of the natural cytotoxicity recep-
tor NKp46 and with lymphoid tissue-inducer (LTi) cells (another
subset of ILCs) the expression of retinoic acid receptor-related
orphan receptor-γt (RORγt). Differently from conventional NK
cells,NKp46+ RORγt+ ILCs produce IL-22 and are non-cytotoxic.
These NKp46+ RORγt+ ILCs are abundantly represented in
mucosal tissues, particularly of the gut and oropharynx (Spits and
Di Santo, 2011).
Finally, much of the studies performed to investigate human
tissue NK cells were not technically able to distinguish between the
two main NK cell subsets, i.e., CD56bright/CD16low/neg/KIRneg NK
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cells (non-cytotoxic) and CD56dim/CD16+ NK cells (cytotoxic).
As a result, a lack of information about relative distribution of
CD56bright and CD56dim NK cells still remains.
Nonetheless, based on the available evidences, it seems that
NK cells are present in healthy skin and gut, in the liver, in
the lungs, and uterus during pregnancy. In addition, human
NK cells were investigated also in other tissues such as the kid-
ney (Schleypen et al., 2006), joints (Dalbeth et al., 2004), and
breast (Faget et al., 2011) under pathophysiological conditions.
In the normal intestinal mucosae, NK cells (Cella et al., 2009;
Reynders et al., 2011) are found predominantly as intraepithe-
lial lymphocytes and within the lamina propria, but are rarely
associated to lymphoid aggregates, although they can be found
in the parafollicular region of cecal lymphoid patches, Peyer’s
patches, and mesenteric lymph nodes (LN, Chinen et al., 2007;
Colonna, 2009; Halama et al., 2011). Detailed analysis of NKp46+
cell population showed that NKp46+ RORγtneg cells found in
the lamina propria, similarly to CD56bright cells in the blood,
express very low levels of perforin, if any, and contain few
granzymes, suggesting that a high percentage of CD56bright cells
localizes in the gut (Chinen et al., 2007; Cella et al., 2009).
Besides mucosae, NK cells seem to be located also in the nor-
mal skin, since it has been reported that few scattered CD56+
CD3− cells are present in the dermis, close to the epidermis,
in skin biopsy specimens from healthy individuals and in non-
lesional skin from atopic eczema/dermatitis syndrome (AEDS)
patients (Buentke et al., 2002). In the liver, NK cells are com-
prised among the non-parenchymal cells that populate this organ.
In steady-state, NK cells are preferentially located in the hepatic
sinusoids, often adhering to the endothelial cells (Krueger et al.,
2011) and NK cells in healthy human liver strikingly account for
almost 20–30% of all human hepatic lymphocytes (Doherty and
O’Farrelly, 2000). Interestingly, the ﬁnding that some liver NK
cells express NKp44 (Burt et al., 2009) raises the question whether
this subpopulation (or at least part of it) may represent acti-
vated NK cells or the IL-22-producing NKp46+ RORγt+ cells,
so far described in the intestine and tonsil. In animals, among
non-lymphoid tissues, the lung contains the largest number of
NK cells (Reynolds et al., 1981; Stein-Streilein et al., 1983; Basse
et al., 1992; Gregoire et al., 2007; Huntington et al., 2007a). Pre-
vious studies located NK cells in the vascular and the interstitial
compartments, with a smaller proportion within the airspaces
and therefore accessible by bronchoalveolar lavage (Weissler et al.,
1987; Basse et al., 1992). However, data available on human
lung NK cells are limited and we recently revisited this topic
and studied the presence and localization of NK cells inﬁltrat-
ing the lung tissues either normal or neoplastic. Our analyses
showed that NKp46+ NK cells actually populate the normal
lung, counting for ∼10% of lymphocytes present in this tissue.
In addition, we observed that the majority (∼80%) of lung-
NK cells belong to the CD56dimCD16+ subset (Carrega et al.,
2008). Similar results were recently reported in mice, where the
CD11bhighCD27dull subset (the murine subset that more similarly
resembles the human CD56dimCD16+ subset) of NK cells was
found to constitute approximately 90% of the lung NK cell pop-
ulation (Hayakawa and Smyth, 2006; Huntington et al., 2007b).
A particular subset of NK cells is found in the placenta, where
it regulates speciﬁc developmental processes at the fetal–maternal
interface. During the ﬁrst trimester of pregnancy, NK cells rep-
resent a subpopulation with unique phenotypic and functional
properties, representing as much as 50–90% of the lymphoid cells
inﬁltrating in this tissue ( King et al., 1991; Bulmer et al., 2010).
Although they are characterized by a CD56brightCD16neg pheno-
type, they differ from their blood counterpart in their expression
of inhibitory receptors and the presence of high levels of lytic
granules. Surprisingly, uterine NK cell rather than act as killers
and/or drivers of inﬂammation, contribute to tissue building
and remodeling and formation of new vessels by releasing high
amounts of IL-8,VEGF, SCF-1-1, and IP-10 but low levels of IFNγ
(Vacca et al., 2011). The presence of NK cells in the major human
organs raises questions about how NK cells reach these peripheral
organs.
FACTORS THAT REGULATE HOMING AND TRAFFICKING OF
HUMAN NK CELLS TO THE TISSUES
The expression of chemokines by organ-speciﬁc cell types suggests
that organ-intrinsic elements may be important in guiding NK cell
homing during physiological and pathological conditions. Differ-
ences between the main human NK cell subsets include also the
expression of chemokine receptors, as CD56dim and CD56bright
NK cell subsets largely differ in their repertoires (Campbell et al.,
2001). However, besides chemokine receptors, it has been demon-
strated thatNK cells can additionallymigrate in response to factors
that do not belong to the chemokine superfamily. This is the case
of the proinﬂammatory protein chemerin and the sphingosine 1-
phosphate (S1P) molecule that can both affect trafﬁcking of NK
cells during inﬂammation or steady-state conditions, respectively
(Parolini et al., 2007; Walzer et al., 2007). On the contrary, the
chemotactic receptors expressed by NKp46 + ILC22 are largely
unknown with the exception of the CCR6 receptor, which seems
to promote leukocyte homing to the gut mucosa (Williams, 2006;
Cella et al., 2009).
Collectively, the different chemokine receptor repertoires
expressed by NK cell subsets may deﬁne entirely different routes
of distribution for these cells. Nevertheless, the detailed migra-
tion patterns of NK cells have not yet been sufﬁciently characte-
rized.
Furthermore, the presence of NK cells in many organs raises
the question whether NK cells can exit the organs, or terminally
reside in the tissues. The localization of NK cells in different tis-
sues would suggest that: (i) they could migrate to various organs,
then reside in the tissue taking on their peculiar activities, per-
haps getting mobilized in the case of disease; alternatively, (ii)
NK cells could re-circulate constantly through the tissues. This
last hypothesis is supported by the ﬁnding that, when trans-
ferred into a naïve syngeneic host, spleen-derived murine NK
cells were found in all the organs where NK cells localize and at
the same proportions as host populations (Gregoire et al., 2007),
thus suggesting that NK cells from one anatomical location are
not restricted to that environment and can re-circulate between
organs. Up to now, it is still unclear which of these alternatives
might be more realistic. Based on the available data, in human,
it is likely that a combination of both scenarios could be pos-
sible. As described above for the gut, liver, and lung, different
Frontiers in Immunology | NK Cell Biology November 2012 | Volume 3 | Article 347 | 2
“ﬁmmu-03-00347” — 2012/11/28 — 17:25 — page 3 — #3
Carrega and Ferlazzo NK cells in human tissues
human solid tissues appear to be populated by different NK
cell subsets (mainly by CD56bright NK cells with some excep-
tion) thus indicating that speciﬁc homing signals are important
to drive localization of NK cells to the different tissues. How-
ever, the ﬁnding that human afferent lymph draining peripheral
tissues contains a substantial number of NK cells (Montalto et al.,
2010; and P. Carrega, personal observation) indicates that NK cells
might even exit the organ and trafﬁc through tissues in normal
conditions.
“IN VIVO” TRAFFICKING OF NATURAL KILLER CELLS
THROUGH SECONDARY LYMPHOID ORGANS
Recent studies have demonstrated that a substantial number of
NK cells are present in resting human LN and the large major-
ity of these LN-NK cells are CD56bright (Fehniger et al., 2003;
Ferlazzo et al., 2004b; Vossen et al., 2008; Ferlazzo and Munz,
2009), as might be predicted by their expression of CCR7 and
L-selectin (CD62L), which binds with high efﬁciency to physio-
logic L-selectin ligands on peripheral LN high endothelial venules
(HEVs). Interestingly, HEVs may not represent the only route
for NK cell entrance in the LN as we recently observed that NK
cells are contained in afferent lymph accumulations following LN
resection upon breast cancer surgery (Montalto et al., 2010; and
P. Carrega, personal observations). This observation is supported
by the ﬁndings that CD56+ lymphocytes were actually detected
in human lymph draining normal skin (Hunger et al., 1999). It
has also been proposed that LN may be sites for NK cell matura-
tion. Like the bone marrow, LN can support the differentiation
of NK cells from NK cell precursors through sequential matura-
tion stages (Freud et al., 2005). Whatever their origin (developed
“in situ” or migrated through blood and afferent lymph), NK
cells are present in the T cell areas of human normal donor
LN (Ferlazzo et al., 2004a,b), indicating LN as potential sites for
DC/NK cell crosstalk (Ferlazzo et al., 2004b). Moreover, by per-
forming real-time observations, it has been shown that more than
90% of the NK cells in the T cell area were found to unam-
biguously remain in contact with the DCs for at least 25 min
(Bajenoff et al., 2006a).
Recently, sequential events regulating the egress of NK cells
from secondary lymphoid organs (SLO) have been described in
the mouse model. Changes in responsiveness of the S1P5 recep-
tor to its ligand (S1P, which concentration is high in peripheral
ﬂuids) seems to have a key role in allowing NK cell exit via lym-
phatics (Mayol et al., 2011). However, whether this mechanism
might also be effective in human has not yet been conﬁrmed.
Notably, the phenotype of NK cells exiting from LN by effer-
ent lymph appears slightly different from that of NK cells found
within these SLO. In particular, part of these cells express signif-
icant amounts of KIR and CD16, implying that CD56bright NK
cells could acquire these molecules in the LN during inﬂamma-
tion and then circulate through the efferent lymph into PB as
KIR+CD16+ NK cells (Romagnani et al., 2007). This notion is
also supported by the ﬁnding that NK cells of highly reactive
LN partially express KIRs and CD16 (Romagnani et al., 2007).
Nevertheless, it cannot be excluded that CD16+KIR+ NK cells
might reach LN because of local inﬂammation, as better discussed
below.
ARE INFLAMED PERIPHERAL TISSUES SITES FOR NK CELL
MATURATION?
It has been demonstrated that, upon activation, CD56bright NK
cells could acquire the signature of CD56dim NK cells, i.e.,
perforin+, KIR+, CD16+, IL-7Rneg, c-kitneg, CXCR3neg, CCR7neg,
CD62Lneg, whereas CD56dim CD16+KIR+ NK cells substantially
maintain their features of terminally differentiated cells (Romag-
nani et al., 2007). Even if this process was elegantly demonstrated
in vitro, the sites and physiological conditions where this pro-
cess may happen remain almost unknown in vivo. Nevertheless,
several observations seem to support the hypothesis that simi-
lar steps of NK cell differentiation occur also in vivo. Indeed, it
has been observed that non-reactive LN contain almost exclu-
sively CD56bright KIRneg CD16neg NK cells, whereas a signiﬁcant
expression of KIR and CD16 is present in NK cells contained in
highly inﬂamed LN and in the efferent lymph. Thus, it could be
envisaged that in steady state or very early during an immune
response, CD56bright KIRneg NK cells can be recruited into LN
(Martin-Fontecha et al., 2004; Bajenoff et al., 2006b), whereas later
on during inﬂammation mature NK cells leave LN and then cir-
culate in PB to reach inﬂamed tissues (Figure 1). Although this
hypothesis is very challenging, it cannot be excluded that the
presence of KIR+CD16+ NK cells in inﬂamed LN (and in the
efferent lymph) might be due to selective migration of this sub-
set into LN. This latter theory is supported by some in vitro data,
which showed that stimulation of human PB CD56dim cells NK
cells with IL-18 can up-regulate their expression of CCR7 (Mail-
liard et al., 2005). However, data derived from the investigation
of tumor-inﬁltrating NK cells, support the hypothesis that, also
in vivo, local activation could convert CD56brightCD16neg NK
cells into effectors analogous to blood CD56dimCD16+ NK cells.
Our observations in NK cells inﬁltrating lung cancers suggest that
up-regulation of KIR on CD56brightCD16neg perforinneg NK cells
can occur also in vivo, most likely because of a proinﬂamma-
tory cytokine microenvironment due to local immune reactions
at the tumor site (Carrega et al., 2008; and P. Carrega, unpub-
lished observations). Therefore, we should consider that, besides
normal distribution and homeostatic re-circulation, the presence
and functions of NK cells in a speciﬁc tissue could also be inﬂu-
enced by in situ differentiation due to local microenvironmental
factors.
CONCLUDING REMARKS
Recent studies have signiﬁcantly increased our knowledge on NK
cell distribution in some human peripheral tissues, such as SLO
and uterus. However, information on NK cells presence in most
human solid tissues, as well as on how NK cell redistribute during
pathological processes, is still largely lacking. Investigations in this
ﬁeld are now highly required in view of novel attempts of NK
cell-based adoptive immunotherapies in both cancer and organ
transplantation settings.
The few earlier data on NK cells inﬁltrating human peripheral
tissues have often been obtained using markers then proved to be
either not sufﬁciently speciﬁc for NK cells or expressed only by
subsets of NK cells. In addition, nowadays, we appreciate that,
in solid tissues, classical NK cells must be distinguished from
other RORγt+ ILCs, which, despite functionally distinct, share
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FIGURE 1 | Hypothesis of NK cell subset recirculation in human
body. After their generation in the bone marrow, CD56bright/perforinneg NK
cells colonize most human tissues according to their chemokine receptor
repertoire. They can eventually acquire cytolytic functions during immune
response in inﬂamed tissues and act locally as innate effector cells.
Alternatively, as depicted, they can reach secondary lymphoid organs
via afferent lymph, acquire perforins and cytolytic functions during
immune reactions occurring in lymphoid organs and then recirculate in
peripheral blood for exerting their protective activities in inﬂamed
tissues.
several conventional NK cell hallmarks. On the basis of what we
learned in the last years regarding innate lymphocytes, some pre-
vious correlations between NK cell inﬁltration and clinical status,
such as cancer prognosis, should now probably be reconsidered
and further dissected.
Apart from these newly described RORγt+ NKp46+ cells,
the most recent analyses on human tissue NK cells have shown
that perforinlow/neg, non-cytotoxic, NKp46+ cells represent in
our body a population of cells much larger than previously
realized. Accumulating evidences are indicating that, in addi-
tion to SLO, also many other human solid tissues, includ-
ing some cancer histotypes, might predominantly host the
CD56bright/KIRneg/perforinneg NKcell subset rather than the cyto-
toxic perforin+ counterpart, which is conversely largely dominant
in PB.
We have recently identiﬁed NKp46+ cells within human affer-
ent lymph and further analyses are currently performed in order to
conﬁrm and extend these preliminary results. Nonetheless, also in
consideration of previous studies on developmental relationships
of NK cell subsets and on the distribution of NK cell subsets in
SLO, inﬂamed tissues, and efferent lymph (Ferlazzo et al., 2004b;
Romagnani et al., 2007), we are now prone to hypothesize that
CD56bright non-cytotoxic NK cells, similarly to naïve T cells, could
re-circulate through afferent lymph fromperipheral tissues to SLO.
Here, they could achieve or not their ﬁnal maturation (depending
on whether or not an immune reaction will occur inside the LN)
and then re-circulate via venous blood vessels or efferent lymph to
PB (Figure 1).
Thus, reactive SLO might be the sites for NK cell ﬁnal matura-
tion, acquisition of cytotoxic properties and tolerance to self (KIR
expression). Complete maturation of NK cells is indeed accom-
panied by the switching of the chemokine receptor repertoire,
which would drive blood re-circulating cytotoxic NK cells toward
their targets in inﬂamed pathological tissues. Alternatively, NK
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cells could also achieve their ﬁnal differentiation steps directly in
inﬂamed tissues, where tissue resident non-cytotoxic CD56bright
perforinneg NK cells might differentiate into perforin+ ﬁnal effec-
tor NK cells during the local immune response against invading
pathogens.
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